Tommy G Thompson
CIK 1324863 · Chairman · last filed 2026-07-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
UTHR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 500
DENVER, CO 80237
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UTHR | Director | 16,680 | $590.20 | $9.84M | -$13.73M | 62 | 2026-07-23 |
| TXMD | Director | 37,491 | $1.79 | $67.3K | $310.4K | 31 | 2025-12-29 |
| HEALTHPEAK PROPERTIES, INC. (PEAK) Delisted | Director | 144,290 | $17.10 | $2.47M | $198.7K | 4 | 2025-05-28 |
| DOC | Director | 156,830 | $19.07 | $2.99M | $1.14M | 19 | 2024-03-01 |
| SCLXW | Director | — | $0.05 | — | $0 | 1 | 2023-01-17 |
| CENTENE CORP (CNTE) Delisted | Director | 287,334 | — | — | -$1.39M | 84 | 2022-01-04 |
| TYME TECHNOLOGIES, INC. (TYME) Delisted | Director | — | $0.31 | — | $0 | 3 | 2019-08-27 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | Director | 9,653 | — | — | $30.2K | 10 | 2016-01-04 |
| Vyant Bio, Inc. (CGIX) Delisted | Director | 2,500 | $4.61 | $11.5K | $0 | 1 | 2013-10-15 |
| AGA Medical Holdings, Inc. (AGAM) Delisted | Director | 0 | — | — | $29.0K | 4 | 2010-11-18 |
Recent Filings · Page 10 of 31
306 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-05-14 | TXMD | Buy (P) | +2,400 | $8.0K | EDGAR |
| 2019-04-25 | CENTENE CORP (CNTE) Delisted | Grant (A) | +3,300 | $200.3K | EDGAR |
| 2019-04-02 | CENTENE CORP (CNTE) Delisted | Grant (A) | +576 | $35.0K | EDGAR |
| 2019-03-19 | UTHR | Exer (M) | +17,100 | $900.3K | EDGAR |
| 2019-03-04 | DOC | Mixed | +8,863 | $160.3K | EDGAR |
| 2019-02-05 | UTHR | Sell (S) | −400 | -$46.8K | EDGAR |
| 2019-01-03 | CENTENE CORP (CNTE) Delisted | Grant (A) | +261 | $35.0K | EDGAR |
| 2018-12-11 | UTHR | Mixed | — | -$52.5K | EDGAR |
| 2018-10-02 | CENTENE CORP (CNTE) Delisted | Grant (A) | +252 | $35.0K | EDGAR |
| 2018-08-28 | TYME TECHNOLOGIES, INC. (TYME) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.